Effect of aerosolized furosemide on the oxygen requirement of preterm neonates

Comparison between efficacy of aerosolized and intravenous furosemide on oxygen requirement in 10 days preterm neonate with oxygen dependency

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140311016936N2

Enrollment

Registered

2019-09-07

Start date

2018-11-21

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic lung disease of preterm neonates (CLD). Acute drug-induced interstitial lung disorders

Interventions

The premature neonates who had inclusion criteria were received aerosolized and intravenous furosemide, respectively..

Eligibility

Sex/Gender

All

Age

10 Days to No maximum

Inclusion criteria

Inclusion criteria: Preterm neonates with gestational age 10 days Preterm neonates who require oxygen

Exclusion criteria

Exclusion criteria: Neonate with major congenital anomalies Neonate with cyanotic heart disease Neonate with renal failure disease Patient who needs corticosteroids in hospital course

Design outcomes

Primary

Measure	Time frame
Ca/Cr ratio of urine. Timepoint: Daily. Method of measurement: Laboratory measurement.;BUN ,Na, K serum. Timepoint: Before drug administration, 49 hours and 97 hours after first doses of drug. Method of measurement: Laboratory measurement.;ABG. Timepoint: Before drug administration, one hour after second and third dose. Method of measurement: Laboratory measurement.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAshkan Nik Aeen

Shiraz University of Medical Sciences

ashkan.nikaeen@gmail.com+98 71 3612 2218

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026